HV

Hariprasad Vankayalapati

Director Director DIN 03068216
DIN 03068216 First appointment May 2010 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2010
Shareholding value •••• Premium profile

About Hariprasad Vankayalapati

Data last updated:

Hariprasad Vankayalapati was a Director at Alveus Pharmaceuticals Private Limited (2010–2019) and Director at Oros Pharmaceuticals Private Limited (2010–2011). The companies operate in Business Outsourcing and Pharma.

DIN 03068216
Primary Designation Director
Industry Business Outsourcing
First Appointment 21 May 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jun 20102009₹1.03 Cr (FY 2016)Strike Off
Oros Pharmaceuticals Private Limited U73100TG2009PTC065273
Director21 May 20102009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alveus Pharmaceuticals Private Limited
Oros Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hariprasad Vankayalapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hariprasad Vankayalapati

Hariprasad Vankayalapati was first appointed on 21 May 2010 as Director at Oros Pharmaceuticals Private Limited.

Hariprasad Vankayalapati held 2 earlier board appointments: Alveus Pharmaceuticals Private Limited (Director, 25 Jun 2010 to 05 Apr 2019); Oros Pharmaceuticals Private Limited (Director, 21 May 2010 to 01 Mar 2011).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available